TENKU
Citius Oncology Inc. - Units (1 Ord & 1 Rts)

0
Loading...
Loading...
News
all
press releases
News Placeholder
TenX Keane Acquisition Announces Contribution to Trust Account in Connection with Extension Amendment Proposal
New York, NY, Jan. 10, 2024 (GLOBE NEWSWIRE) -- TenX Keane Acquisition (Nasdaq: TENKU, TENK, TENKR) (the Company ), announced today that if the proposal to amend the Company's Amended and Restated...
Globe Newswire·2y ago
News Placeholder
Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2023 Financial Results and Provides Business Update
Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2023 Financial Results and Provides Business Update Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2023 Financial Results and Provides...
PR Newswire·2y ago

Latest TENKU News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.